Nitrazepam

Nitrazepam acts on the central nervous system to produce sedative‑hypnotic and anxiolytic effects. It is prescribed for several well‑established conditions:

• Insomnia: Improves sleep onset and maintenance in patients with difficulty falling or staying asleep.
• Anxiety disorders: Reduces excessive worry and tension during acute episodes.
• Epilepsy (seizure control): Provides adjunctive control of certain seizure types, especially when other therapies are insufficient.

• Nitrazepam binds to a distinct site on the GABA_A receptor complex, acting as a positive allosteric modulator. This enhances the inhibitory effect of gamma‑aminobutyric acid (GABA) by increasing chloride ion influx into neurons, leading to hyperpolarization of neuronal membranes and a generalized depressant effect on central nervous system activity.

Nitrazepam may cause a range of adverse reactions, varying from mild to severe.

Common Side Effects

• Drowsiness: Feeling unusually sleepy during daytime activities.
• Dizziness: Light‑headed sensation, especially when standing quickly.
• Impaired coordination: Reduced motor control and balance.
• Memory impairment: Difficulty recalling recent events.
• Fatigue: Persistent lack of energy.
• Headache: Mild to moderate head pain.

Serious or Rare Side Effects

• Respiratory depression: Slow or shallow breathing, particularly with other depressants.
• Severe allergic reaction: Rash, itching, swelling, or difficulty breathing.
• Depression or suicidal thoughts: Mood changes requiring immediate medical attention.
• Paradoxical agitation: Increased anxiety or aggression instead of calming.
• Dependence and withdrawal: Physical reliance after prolonged use.
• Hepatic dysfunction: Abnormal liver enzyme levels.

Before initiating nitrazepam therapy, several safety considerations should be addressed.

• Assess renal and hepatic function: Adjust use if organ impairment is present.
• Avoid abrupt discontinuation: Taper the dose under medical supervision to prevent withdrawal.
• Use caution in elderly patients: Increased risk of falls and cognitive impairment.
• Avoid concurrent alcohol or CNS depressants: Additive sedation may occur.
• Pregnancy and lactation: Consult a healthcare professional as safety data are limited.
• Store at ambient temperature: Keep in the original container, protect from moisture and direct sunlight.

Nitrazepam can interact with various medicines, influencing its efficacy and safety.

Major Interactions (Avoid)

• Opioids or other CNS depressants: May cause profound sedation or respiratory depression.
• Alcohol: Enhances sedative effects and impairs coordination.
• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): Increase nitrazepam plasma concentrations.

Moderate Interactions (Monitor Closely)

• CYP3A4 inducers (e.g., carbamazepine, rifampicin): May reduce therapeutic effect.
• Antidepressants (e.g., SSRIs, SNRIs): Potentially increase sedation.
• Antihistamines: Additive drowsiness may occur.